NDC 17856-0021

Renagel

Renagel

Renagel is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Atlantic Biologicals Corps. The primary component is Sevelamer Hydrochloride.

Product ID17856-0021_42719fda-d898-4749-b561-f85a5e54cd06
NDC17856-0021
Product TypeHuman Prescription Drug
Proprietary NameRenagel
Generic NameRenagel
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2008-06-06
Marketing CategoryNDA / NDA
Application NumberNDA021179
Labeler NameAtlantic Biologicals Corps
Substance NameSEVELAMER HYDROCHLORIDE
Active Ingredient Strength800 mg/1
Pharm ClassesPhosphate Binder [EPC],Phosphate Chelating Activity [MoA]
NDC Exclude FlagE
Listing Certified Through2018-12-31

Packaging

NDC 17856-0021-2

1 TABLET in 1 POUCH (17856-0021-2)
Marketing Start Date2008-06-06
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 17856-0021-2 [17856002102]

Renagel TABLET
Marketing CategoryNDA
Application NumberNDA021179
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2008-06-06
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
SEVELAMER HYDROCHLORIDE800 mg/1

OpenFDA Data

SPL SET ID:ee835dc1-36b7-4447-a5c6-5ed9e06a839d
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 857224
  • Pharmacological Class

    • Phosphate Binder [EPC]
    • Phosphate Chelating Activity [MoA]

    NDC Crossover Matching brand name "Renagel" or generic name "Renagel"

    NDCBrand NameGeneric Name
    17856-0021RenagelRenagel
    53808-0777RenagelRenagel
    58468-0020RenagelRenagel
    58468-0021Renagelsevelamer hydrochloride
    67544-656RenagelRenagel
    68151-4295RENAGELRenagel

    Trademark Results [Renagel]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    RENAGEL
    RENAGEL
    74590044 1978935 Live/Registered
    GENZYME CORPORATION
    1994-10-24

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.